Recently, it was learned from the competent department that the "ERP/MES" of Peak Pharmaceutical CompanyThe "whole process informatization" project has been included in the list of key projects of "integration of industrialization and industrialization" in Jinhua City, and has now entered the publicity period.

In order to speed up the deep integration of informatization and industrialization, according to the evaluation criteria in Jinhua City's "Several Opinions on Accelerating Informatization Construction" and "Jinhua City Informatization and Industrialization Integration Key Project Management Measures", there are 148The project was included in the key project of "integration of the two" in Jinhua City in 2017. Jianfeng Pharmaceutical's "ERP/MES Full Process Informatization" project was finally included in the list after recommend, material review and expert review by Jinhua Economic and Information Commission.

ERP/KNIFEERP for full-process information projectsThe subsystems at the level include sales system, purchasing system, MRP system, GMP QbD system, connecting UFIDA financial software and HR system. MES-level subsystems include industrial data acquisition and monitoring system, GAMP/MES system, eBPR (electronic batch production record system), cGMP quality assurance system, QC/eBTR (QC process and electronic batch inspection record system), LIMS system, etc. After the construction is completed, the visualization of drug production process and the collection and integration of industrial data will be realized. Realize the electronization of drug production process parameters, electronic batch production and inspection records; the realization of big data integration of industrial data and information will also be in line with the regulatory concept of GMP data integrity and quality traceability to the greatest extent. The establishment of a unified enterprise information platform will eliminate information islands and realize data integration, which will help ensure the quality of drugs, greatly improve work efficiency, reduce business risks, and provide assistance to the internationalization of peak pharmaceutical products.